Hoosing the tumoral epilepsy surgery candidate

Epilepsia

Volumn 54, Issue SUPPL. 9, 2013, Pages 91-96

  Rheims, Sylvain ^a,b   Ducray, François ^a   Ryvlin, Philippe ^a,b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b LYON NEUROSCIENCE RESEARCH CENTER   (France)

^c Department of Functional Neurology and Epileptology ^*  (France)

Author keywords

Brain tumors; Epilepsy; Epilepsy surgery; Glioma; Glioneuronal tumor

Indexed keywords

BRAIN TUMOR; BRAIN TUMORS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; EPILEPSY; EPILEPSY SURGERY; GLIOMA; GLIONEURONAL TUMOR; HUMAN; METHODOLOGY; NEUROSURGERY; PATIENT SELECTION; REVIEW; BRAIN NEOPLASMS; COMPLICATION; PROCEDURES;

BRAIN TUMORS; EPILEPSY; EPILEPSY SURGERY; GLIOMA; GLIONEURONAL TUMOR;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; HUMANS; NEUROSURGICAL PROCEDURES; PATIENT SELECTION;

EID: 84894378372     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12451     Document Type: Article

References (33)

1. Aaronson NK, Taphoorn MJ, Heimans JJ, Postma TJ, Gundy CM, Beute GN, Slotman BJ, Klein M. (2011) Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol 29:4430-4435.
2. Adachi Y, Sato N, Okamoto T, Sasaki M, Komaki H, Yamashita F, Kida J, Takahashi T, Matsuda H. (2011) Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. Neuroradiology 53:3-11.
3. Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, Vander Heiden MG, Sorensen AG. (2012) Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 4:116ra4.
4. Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H. (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1269-1274.
5. Campos AR, Clusmann H, von Lehe M, Niehusmann P, Becker AJ, Schramm J, Urbach H. (2009) Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants: clinical profile, MRI, and histopathology. Neuroradiology 51:433-443.
6. Cavaliere R, Lopes MB, Schiff D. (2005) Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 4:760-770.
7. Chassoux F, Rodrigo S, Mellerio C, Landre E, Miquel C, Turak B, Laschet J, Meder JF, Roux FX, Daumas-Duport C, Devaux B. (2012) Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology 79:1699-1707.
8. Daumas-Duport C. (1993) Dysembryoplastic neuroepithelial tumours. Brain Pathol 3:283-295.
9. Daumas-Duport C, Varlet P, Bacha S, Beuvon F, Cervera-Pierot P, Chodkiewicz JP. (1999) Dysembryoplastic neuroepithelial tumors: nonspecific histological forms - a study of 40 cases. J Neurooncol 41:267-280.
10. Duffau H. (2012) Awake surgery for incidental WHO grade II gliomas involving eloquent areas. Acta Neurochir (Wien) 154:575-584; discussion 584.
11. Englot DJ, Berger MS, Barbaro NM, Chang EF. (2011) Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 115:240-244.
12. Englot DJ, Berger MS, Chang EF, Garcia PA. (2012a) Characteristics and treatment of seizures in patients with high-grade glioma: a review. Neurosurg Clin N Am 23:227-235, vii-viii.
13. Englot DJ, Berger MS, Barbaro NM, Chang EF. (2012b) Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia 53:51-57.
14. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG. (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed braintumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886-1893.
15. Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgard G, Solheim O. (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881-1888.
16. Juhasz C, Chugani DC, Muzik O, Wu D, Sloan AE, Barger G, Watson C, Shah AK, Sood S, Ergun EL, Mangner TJ, Chakraborty PK, Kupsky WJ, Chugani HT. (2006) In vivo uptake and metabolism of alpha- [11C]methyl-L-tryptophan in human brain tumors. J Cereb Blood Flow Metab 26:345-357.
17. Kasper BS, Struffert T, Kasper EM, Fritscher T, Pauli E, Weigel D, Kerling F, Hammen T, Graf W, Kuwert T, Prante O, Lorber B, Buchfelder M, Doerfler A, Schwab S, Stefan H, Linke R. (2011) 18Fluoroethyl-L-tyrosine-PET in long-term epilepsy associated glioneuronal tumors. Epilepsia 52:35-44.
18. McGirt MJ, Woodworth GF, Coon AL, Frazier JM, Amundson E, Garonzik I, Olivi A, Weingart JD. (2005) Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 102:897-901.
19. Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. (2005) Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 4:627-634.
20. Pace A, Villani V, Di Lorenzo C, Guariglia L, Maschio M, Pompili A, Carapella CM. (2013) Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neurooncol 111:83-86.
21. Pichler R, Dunzinger A, Wurm G, Pichler J, Weis S, Nussbaumer K, Topakian R, Aigner RM. (2010) Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance' Eur J Nucl Med Mol Imaging 37:1521-1528.
22. Ray WZ, Blackburn SL, Casavilca-Zambrano S, Barrionuevo C, Orrego JE, Heinicke H, Dowling JL, Perry A. (2009) Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol 94:283-292.
23. Rheims S, Rubi S, Bernard E, Bouvard S, Streichenberger N, Guenot M, Ryvlin P. (2012) Diagnostic accuracy of [11C]-methionine PET for the differatiation between dysembryoplastic neuroepithelial tumour and other epileptogenic brain neoplasms. Epilepsia 53:204.
24. Rosenberg DS, Demarquay G, Jouvet A, Le Bars D, Streichenberger N, Sindou M, Kopp N, Mauguiere F, Ryvlin P. (2005) [11C]- Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms. J Neurol Neurosurg Psychiatry 76:1686-1692.
25. Ruda R, Trevisan E, Soffietti R. (2010) Epilepsy and brain tumors. Curr Opin Oncol 22:611-620.
26. Ryvlin P, Rheims S. (2008) Epilepsy surgery: eligibility criteria and presurgical evaluation. Dialogues Clin Neurosci 10:91-103.
27. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3-8.
28. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338-1345.
29. Southwell DG, Garcia PA, Berger MS, Barbaro NM, Chang EF. (2012) Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery 70:1406-1413; discussion 1413-1414.
30. Stanescu Cosson R, Varlet P, Beuvon F, Daumas Duport C, Devaux B, Chassoux F, Fredy D, Meder JF. (2001) Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J Neuroradiol 28:230-240.
31. Valenti MP, Froelich S, Armspach JP, Chenard MP, Dietemann JL, Kerhli P, Marescaux C, Hirsch E, Namer IJ. (2002) Contribution of SISCOM imaging in the presurgical evaluation of temporal lobe epilepsy related to dysembryoplastic neuroepithelial tumors. Epilepsia 43:270-276.
32. van Breemen MS, Wilms EB, Vecht CJ. (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421-430.
33. Yavas C, Zorlu F, Ozyigit G, Gurkaynak M, Yavas G, Yuce D, Cengiz M, Yildiz F, Akyol F. (2012) Health-related quality of life in highgrade glioma patients: a prospective single-center study. Support Care Cancer 20:2315-2325.